LORLATINIB
B7461039
Approved small_molecule active
Quick answer
LORLATINIB for Lung cancer is a Approved program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- Lung cancer
- Phase
- Approved
- Modality
- small_molecule
- Status
- active